Trajan supports distribution partners at ArabLab 2016

Trajan supports distribution partners at ArabLab 2016

April 04, 2016

Trajan Scientific and Medical (Trajan) was pleased to support its distribution partners Kinesis Ltd and Gulf Analytical Supplies FZE at ArabLab 2016 held at the Dubai International Convention and Exhibition Centre from 20 - 23 March 2016.

With over 10,000 visitors from 101 countries visiting 1,000 exhibiting companies, it was a fantastic opportunity to for Trajan to join Kinesis Ltd and Gulf Analytical Supplies through both seminar presentation and booth presence.

Mr Andy Hall, Trajan’s Distribution and Operations Manager, Europe, Middle East, Africa, said end-users, manufacturers and distributors had traveled from all over the region and beyond to attend the event, and the quality of discussions about future opportunities to work with Trajan products was very positive.

Together with Mr Akram Hussain from Kinesis Ltd, Mr Hall presented Trajan’s SGE eVol, world’s first digital analytical syringe in a delegate seminar, explaining the features and benefits of using eVol compared to traditional laboratory workflows. Further details about this innovative device can be found in the seminar presentation notes below.

“At Arablab 2016 Trajan’s distributors in the region came away with strong new leads and contacts, and I am confident these engagements will to a sustained growth for their sales of Trajan’s SGE brand chromatography products,” said Mr Hall.

Mr Andy Hall, presenting eVol with Kinesis at ArabLab 2016
Photo: Mr Andy Hall, Trajan's Distribution and Operations Manager, Europe, Middle East, Africa, presenting eVol with Kinesis at ArabLab 2016

Downloads
PP-0022 Trajan Scientific and Medical with Kinesis - ArabLab 2016 eVol Presentation

More information
europe@trajanscimed.com
www.sge.com/evol




Also in News

Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst
Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst

September 07, 2020

Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.

Read More

European patent for Trajan’s hemaPEN
European patent for Trajan’s hemaPEN

July 13, 2020

Trajan Scientific and Medical is proud to advise that the European Patent Office will be granting a patent for hemaPEN® as a liquid collection device in Belgium, France, Germany, Ireland, Luxembourg, Monaco, Switzerland, Liechtenstein and the United Kingdom. Extensions are being sought across the remainder of Europe.

Read More

US FDA listing of Trajan’s hemaPEN blood microsampling device
US FDA listing of Trajan’s hemaPEN blood microsampling device

July 02, 2020

Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.

Read More